iResearch Atlanta

Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT

Kimball A. Johnson, Nancy Martin, Rossella E. Nappi et al. · The Journal of Clinical Endocrinology & Metabolism · 2023 · 173 citations · Full text

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age

Evan J. Anderson, C. Buddy Creech, Vladimir Berthaud et al. · New England Journal of Medicine · 2022 · 136 citations · Full text

Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study

Gerard Sanacora, Michael R. Johnson, Arif Khan et al. · Neuropsychopharmacology · 2016 · 114 citations · Full text

Treating moderate-to-severe menopausal vasomotor symptoms with fezolinetant: analysis of responders using pooled data from two phase 3 studies (SKYLIGHT 1 and 2)

Rossella E. Nappi, Kimball A. Johnson, Petra Stute et al. · Menopause The Journal of The North American Menopause Society · 2024 · 10 citations · Full text